Benzodiazepines

Benzodiazepines are central nervous system depressants that enhance the inhibitory neurotransmitter GABA. Medically prescribed for anxiety, insomnia, seizures, and muscle tension, they carry high addiction potential and significant overdose risk, especially when combined with other depressants or counterfeit products containing fentanyl.

How It Works

Positive allosteric modulators of GABA-A receptors that increase the frequency of chloride channel opening, enhancing neuronal inhibition and reducing excitability throughout the central nervous system.

Legal Status

Schedule IV controlled substances in the US (DEA); prescription-only medications in most countries. Possession without prescription is illegal. Counterfeit pills frequently sold on illicit markets may contain fentanyl or other dangerous adulterants.

Dosage Guide (Oral (alprazolam equivalent))

Note: Potency varies enormously between benzos. Alprazolam is ~2x stronger than diazepam. Flunitrazepam is extremely potent (~10x alprazolam). Counterfeit pressed pills may contain fentanyl — always test. Never increase dose without medical supervision; tolerance develops rapidly.

Organ System Impacts

cardiovascular — Moderate

Mild hypotension, decreased heart rate. Risk of severe hypotension with high doses or IV administration. Increased risk of cardiovascular events in elderly patients.

neurological — High

CNS depression, impaired cognition, memory dysfunction, potential seizures upon abrupt withdrawal. Long-term use associated with cognitive decline and potential neurotoxicity.

ocular — Low

Blurred vision, diplopia, nystagmus, difficulty with visual accommodation. Pupil constriction (miosis).

dermatological — Low

Rashes (rare), photosensitivity potential. IV use increases infection and abscess formation.

respiratory — High

Respiratory depression, reduced respiratory drive, apnea risk (especially with high doses or other depressants). Potentially fatal in overdose.

hepatic — Moderate

Benzodiazepines metabolized by liver; chronic use increases risk of hepatic dysfunction. Impaired metabolism in patients with liver disease prolongs effects.

hematological — Low

Rare cases of agranulocytosis or leukopenia reported. Generally minimal impact.

renal — Low

Minimal direct renal toxicity. Metabolites cleared by kidneys; impaired clearance in renal disease.

gastrointestinal — Low

Nausea, constipation, dry mouth, appetite changes. Usually mild and dose-dependent.

musculoskeletal — Low

Muscle relaxation (therapeutic effect), but also weakness and impaired coordination. Increased fall risk in elderly.

Effects

Desired Effects

• Anxiety reduction
• Relaxation and sedation
• Muscle relaxation
• Reduction in panic symptoms
• Sleep induction
• Sense of calm and detachment

Negative Effects

• Respiratory depression
• Cognitive impairment and confusion
• Memory gaps (anterograde amnesia)
• Dependence with regular use
• Rebound anxiety after cessation
• Dizziness and vertigo
• Blurred vision
• Impaired judgment and decision-making

Rare but Serious

• Respiratory arrest
• Coma
• Paradoxical aggression or disinhibition
• Severe depression
• Suicidal ideation
• Status epilepticus (if abruptly discontinued in seizure patients)

Drug Interactions

Detection Times

Benzodiazepines are included in standard drug panels. Long-acting benzos have extended windows.

Urine

Standard immunoassay. Short-acting: 3-5 days. Long-acting (diazepam): up to 30 days. Detection window: up to 14 days.

Blood

Blood detection varies by specific benzodiazepine. Detection window: up to 3 days.

Hair

Hair follicle testing detects benzodiazepine use. Detection window: up to 90 days.

Saliva

Oral fluid testing for recent use. Detection window: up to 3 days.

Harm Reduction Tips

• NEVER mix with opioids unless under strict medical supervision with naloxone access. Benzodiazepine-opioid combinations cause most polysubstance overdose deaths.

• If you use, test your pills with reagent tests (Mandelin, Mecke, Simon's) to check for fentanyl contamination. Counterfeit pills are extremely common and frequently contain fentanyl.

• Use oral route only if using non-medically. Intranasal/IV use dramatically increases addiction potential, overdose risk, and infection risks.

• Keep naloxone (Narcan) available if using with other depressants. Naloxone does NOT effectively reverse benzodiazepine overdose alone, but may help with mixed overdoses.

• If dependent or regular user, NEVER stop abruptly or 'cold turkey.' This can cause seizures, which are potentially fatal. Medical taper under supervision is essential. Typical taper: reduce by 5-10% every 1-2 weeks.

• NEVER mix with alcohol or other CNS depressants. This is the leading cause of benzodiazepine-related deaths.

• Never use alone if possible. If alone, set up a check-in system with a friend and use a service like NECT (Never Use Alone hotline).

• Start with lowest effective dose. Tolerance develops rapidly; avoid escalating doses. If tolerance develops, consult a healthcare provider rather than self-increasing.

• If using IV: use sterile equipment (new needle/syringe every time), do not share equipment, clean injection sites with alcohol wipe, and rotate injection sites.

• Avoid driving or operating machinery. Benzodiazepines significantly impair coordination and cognition.

• Be aware of amnestic properties. Benzodiazepines cause blackouts (memory gaps without loss of consciousness), particularly with alcohol.

• If experiencing depression or suicidal thoughts, discuss with healthcare provider immediately. Benzodiazepines can increase these risks.

Withdrawal Symptoms

Severity: Dangerous

Short-acting (alprazolam, lorazepam): onset 1-2 days, peak 2-5 days. Long-acting (diazepam, clonazepam): onset 2-7 days, peak 1-2 weeks. Protracted withdrawal syndrome: months to years (anxiety, insomnia, sensory issues). Taper schedule: 10% reduction every 1-2 weeks minimum.

Physical

• Tremors
• Muscle tension and pain
• Tachycardia and palpitations
• Sweating
• Seizures (potentially fatal)
• Headaches
• Nausea
• Sensory hypersensitivity (light, sound, touch)

Psychological

• Rebound anxiety (often worse than original)
• Insomnia (severe)
• Panic attacks
• Irritability and agitation
• Depersonalization/derealization
• Depression
• Cognitive impairment
• Psychosis in severe cases

Emergency Information

Call 911 If:

• Person is unresponsive or unconscious
• Respiratory rate below 8 breaths per minute or severely shallow
• Blue lips, fingertips, or tongue
• Seizures occurring
• Severe confusion or difficulty staying awake
• Suspected polysubstance overdose (especially with opioids or alcohol)
• Person cannot be roused

Warning Signs

• Severe respiratory depression or shallow breathing
• Loss of consciousness or difficulty staying awake
• Confusion or disorientation
• Extreme drowsiness unresponsive to stimulation
• Blue lips or fingertips (cyanosis)
• Weak or undetectable pulse
• Seizures
• Rigid muscles
• In suspected polysubstance overdose: pinpoint pupils (opioid sign)

What To Do

1. Call 911 immediately if any overdose signs present
2. Move person to recovery position (on side) if unresponsive but breathing
3. If opioid co-use suspected, administer naloxone (Narcan) immediately — it will not harm if opioids not present
4. Check for breathing every 10 seconds
5. Perform rescue breathing/CPR if trained and person not breathing
6. Do not give flumazenil (Romazicon) — it increases seizure risk and should only be used by medical professionals in specific settings
7. Stay with person until emergency services arrive
8. Provide emergency responders with information on all substances used